These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27054572)

  • 21. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
    Limou S; Nelson GW; Lecordier L; An P; O'hUigin CS; David VA; Binns-Roemer EA; Guiblet WM; Oleksyk TK; Pays E; Kopp JB; Winkler CA
    Kidney Int; 2015 Oct; 88(4):754-63. PubMed ID: 25993319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.
    Atta MG; Estrella MM; Kuperman M; Foy MC; Fine DM; Racusen LC; Lucas GM; Nelson GW; Warner AC; Winkler CA; Kopp JB
    Kidney Int; 2012 Aug; 82(3):338-43. PubMed ID: 22495294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD.
    Palmer ND; Ng MC; Langefeld CD; Divers J; Lea JP; Okusa MD; Kimberly RP; Bowden DW; Freedman BI
    J Am Soc Nephrol; 2015 May; 26(5):1021-5. PubMed ID: 25249559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.
    Nadkarni GN; Galarneau G; Ellis SB; Nadukuru R; Zhang J; Scott SA; Schurmann C; Li R; Rasmussen-Torvik LJ; Kho AN; Hayes MG; Pacheco JA; Manolio TA; Chisholm RL; Roden DM; Denny JC; Kenny EE; Bottinger EP
    J Am Coll Cardiol; 2017 Mar; 69(12):1564-1574. PubMed ID: 28335839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.
    Kormann R; Jannot AS; Narjoz C; Ribeil JA; Manceau S; Delville M; Joste V; Prié D; Pouchot J; Thervet E; Courbebaisse M; Arlet JB
    Br J Haematol; 2017 Oct; 179(2):323-335. PubMed ID: 28699644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide association study for time to failure of kidney transplants from African American deceased donors.
    Divers J; Ma L; Brown WM; Palmer ND; Choi Y; Israni AK; Pastan SO; Julian BA; Gaston RS; Hicks PJ; Reeves-Daniel AM; Freedman BI
    Clin Transplant; 2020 Jun; 34(6):e13827. PubMed ID: 32080893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Apolipoprotein L1 Gene and Cardiovascular Disease.
    Robinson TW; Freedman BI
    Methodist Debakey Cardiovasc J; 2016; 12(4 Suppl):2-5. PubMed ID: 28298955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. African American living-kidney donors should be screened for APOL1 risk alleles.
    Cohen DM; Mittalhenkle A; Scott DL; Young CJ; Norman DJ
    Transplantation; 2011 Oct; 92(7):722-5. PubMed ID: 21878839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.
    Tin A; Grams ME; Maruthur NM; Astor BC; Couper D; Mosley TH; Fornage M; Parekh RS; Coresh J; Kao WH
    Clin J Am Soc Nephrol; 2015 May; 10(5):784-90. PubMed ID: 25887069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A tripartite complex of suPAR, APOL1 risk variants and α
    Hayek SS; Koh KH; Grams ME; Wei C; Ko YA; Li J; Samelko B; Lee H; Dande RR; Lee HW; Hahm E; Peev V; Tracy M; Tardi NJ; Gupta V; Altintas MM; Garborcauskas G; Stojanovic N; Winkler CA; Lipkowitz MS; Tin A; Inker LA; Levey AS; Zeier M; Freedman BI; Kopp JB; Skorecki K; Coresh J; Quyyumi AA; Sever S; Reiser J
    Nat Med; 2017 Aug; 23(8):945-953. PubMed ID: 28650456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index.
    Julian BA; Gaston RS; Brown WM; Reeves-Daniel AM; Israni AK; Schladt DP; Pastan SO; Mohan S; Freedman BI; Divers J
    Am J Transplant; 2017 Jun; 17(6):1540-1548. PubMed ID: 27862962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
    N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status.
    Estrella MM; Li M; Tin A; Abraham AG; Shlipak MG; Penugonda S; Hussain SK; Palella FJ; Wolinsky SM; Martinson JJ; Parekh RS; Kao WH
    Clin Infect Dis; 2015 Feb; 60(4):646-52. PubMed ID: 25281610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein domains of APOL1 and its risk variants.
    Lan X; Wen H; Lederman R; Malhotra A; Mikulak J; Popik W; Skorecki K; Singhal PC
    Exp Mol Pathol; 2015 Aug; 99(1):139-44. PubMed ID: 26091559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Target organ damage in African American hypertension: role of APOL1.
    Freedman BI; Murea M
    Curr Hypertens Rep; 2012 Feb; 14(1):21-8. PubMed ID: 22068337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
    Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of Injury in APOL1-associated Kidney Disease.
    Ma L; Divers J; Freedman BI
    Transplantation; 2019 Mar; 103(3):487-492. PubMed ID: 30371607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.
    Olabisi OA; Zhang JY; VerPlank L; Zahler N; DiBartolo S; Heneghan JF; Schlöndorff JS; Suh JH; Yan P; Alper SL; Friedman DJ; Pollak MR
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):830-7. PubMed ID: 26699492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should kidney donors be genotyped for APOL1 risk alleles?
    Freedman BI; Julian BA
    Kidney Int; 2015 Apr; 87(4):671-3. PubMed ID: 25826538
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.
    Bostrom MA; Kao WH; Li M; Abboud HE; Adler SG; Iyengar SK; Kimmel PL; Hanson RL; Nicholas SB; Rasooly RS; Sedor JR; Coresh J; Kohn OF; Leehey DJ; Thornley-Brown D; Bottinger EP; Lipkowitz MS; Meoni LA; Klag MJ; Lu L; Hicks PJ; Langefeld CD; Parekh RS; Bowden DW; Freedman BI;
    Am J Kidney Dis; 2012 Feb; 59(2):210-21. PubMed ID: 22119407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.